56
Views
10
CrossRef citations to date
0
Altmetric
Perspective

Human VIP-α: an emerging biologic response modifier to treat primary pulmonary hypertension

Pages 565-569 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Cecile Tissot & Maurice Beghetti. (2009) Advances in therapies for pediatric pulmonary arterial hypertension. Expert Review of Respiratory Medicine 3:3, pages 265-282.
Read now
Erika B Rosenzweig. (2006) Emerging treatments for pulmonary arterial hypertension. Expert Opinion on Emerging Drugs 11:4, pages 609-619.
Read now

Articles from other publishers (8)

Hoi Soo YoonYong Sung ChoiEun Hye Lee. (2013) Biologic response modifiers. Journal of the Korean Medical Association 56:2, pages 135.
Crossref
Reshma S. Baliga, Raymond J. MacAllister & Adrian J. Hobbs. 2013. Pharmacotherapy of Pulmonary Hypertension. Pharmacotherapy of Pulmonary Hypertension 477 511 .
Reshma S. Baliga, Raymond J. MacAllister & Adrian J. Hobbs. 2013. Pharmacotherapy of Pulmonary Hypertension. Pharmacotherapy of Pulmonary Hypertension 477 511 .
Cécile Tissot & Maurice Beghetti. 2012. Pediatric Cardiovascular Medicine. Pediatric Cardiovascular Medicine 730 752 .
W. Mosgoeller, R. Prassl & A. Zimmer. 2012. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases 325 354 .
Dongmei Wu, Dongwon Lee & Yong Kiel Sung. (2011) Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review. Respiratory Research 12:1.
Crossref
Yoshitaka Umetsu, Takeshi Tenno, Natsuko Goda, Masahiro Shirakawa, Takahisa Ikegami & Hidekazu Hiroaki. (2011) Structural difference of vasoactive intestinal peptide in two distinct membrane-mimicking environments. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1814:5, pages 724-730.
Crossref
S G R Smalley, P A Barrow & N Foster. (2009) Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease. Clinical and Experimental Immunology 157:2, pages 225-234.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.